Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
1,064 INR | -2.26% | +6.70% | +54.37% |
05-21 | Nomura Downgrades Zydus Lifesciences to Neutral From Buy, Adjusts Price Target to INR1,020 From INR988 | MT |
05-21 | Zydus Lifesciences Records Sharp Rise in Fiscal Q4 Consolidated Profit | MT |
This article is reserved for subscribers
Signed up already?
Log InNot subscribed yet?
SubscribeEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+54.37% | 13.15B | |
+20.78% | 44.39B | |
+20.08% | 22.46B | |
+17.81% | 15.04B | |
+18.35% | 13.98B | |
-10.55% | 6.89B | |
-0.05% | 6.79B | |
+14.03% | 5.71B | |
-8.87% | 5.73B | |
+6.11% | 4.69B |
- Stock Market
- Equities
- ZYDUSLIFE Stock
- News Zydus Lifesciences Limited
- Transcript : Zydus Lifesciences Limited, Q2 2024 Earnings Call, Nov 07, 2023